TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.
Journal
Clinical pharmacology and therapeutics
ISSN: 1532-6535
Titre abrégé: Clin Pharmacol Ther
Pays: United States
ID NLM: 0372741
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
04
06
2023
accepted:
28
07
2023
pubmed:
2
9
2023
medline:
2
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
Environmental health science seeks to predict how environmental toxins, chemical toxicants, and prescription drugs accumulate and interact within the body. Xenobiotic transporters of the ATP-binding cassette (ABC) and solute carrier (SLC) superfamilies are major determinants of the uptake and disposition of xenobiotics across the kingdoms of life. The goal of this study was to integrate drug and environmental chemical interactions of mammalian ABC and SLC proteins in a centralized, integrative database. We built upon an existing publicly accessible platform-the "TransPortal"-which was updated with novel data and searchable features on transporter-interfering chemicals from manually curated literature data. The integrated resource TransPortal-TICBase (https://transportal.compbio.ucsf.edu) now contains information on 46 different mammalian xenobiotic transporters of the ABC- and SLC-type superfamilies, including 13 newly added rodent and 2 additional human drug transporters, 126 clinical drug-drug interactions, and a more than quadrupled expansion of the initial in vitro chemical interaction data from 1,402 to 6,296 total interactions. Based on our updated database, environmental interference with major human and rodent drug transporters occurs across the ABC- and SLC-type superfamilies, with kinetics indicating that some chemicals, such as the ionic liquid 1-hexylpyridinium chloride and the antiseptic chlorhexidine, can act as strong inhibitors with potencies similar or even higher than pharmacological model inhibitors. The new integrated web portal serves as a central repository of current and emerging data for interactions of prescription drugs and environmental chemicals with human drug transporters. This archive has important implications for predicting adverse drug-drug and drug-environmental chemical interactions and can serve as a reference website for the broader scientific community of clinicians and researchers.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1293-1303Informations de copyright
© 2023 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
Références
Schecter, A. et al. Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ. Health Perspect. 118, 796-802 (2010).
CDC. National Report on Human Exposure to Environmental Chemicals. Updated March 2022. <https://www.cdc.gov/exposurereport/index.html> (2022). Accessed November 11, 2022.
Nicklisch, S.C.T., Bonito, L.T., Sandin, S. & Hamdoun, A. Geographic differences in persistent organic pollutant levels of yellowfin tuna. Environ. Health Perspect. 125, 067014 (2017).
Alharbi, O.M.L., Basheer, A.A., Khattab, R.A. & Ali, I. Health and environmental effects of persistent organic pollutants. J. Mol. Liq. 263, 442-453 (2018).
Wahlang, B. Exposure to persistent organic pollutants: impact on women's health. Rev. Environ. Health 33, 331-348 (2018).
Doring, B. & Petzinger, E. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism. Drug Metab. Rev. 46, 261-282 (2014).
Giacomini, K.M. & Sugiyama, Y. Membrane transporters and drug response. In Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14e (eds. Brunton, L.L. & Knollmann, B.C.) (New York, NY: McGraw-Hill Education, 2023).
Koziolek, M. et al. The mechanisms of pharmacokinetic food-drug interactions-a perspective from the UNGAP group. Eur. J. Pharm. Sci. 134, 31-59 (2019).
Nguyen, J.T. et al. Assessing transporter-mediated natural product-drug interactions via in vitro-in vivo extrapolation: clinical evaluation with a probe cocktail. Clin. Pharmacol. Ther. 109, 1342-1352 (2021).
Giacomini, K.M. et al. New and emerging research on solute carrier and ATP binding cassette transporters in drug discovery and development: outlook from the international transporter consortium. Clin. Pharmacol. Ther. 112, 540-561 (2022).
Cooper-DeHoff, R.M., Niemi, M., Ramsey, L.B. et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms. Clin. Pharmacol. Ther. 111, 1007-1021 (2022).
Shukla, S., Ohnuma, S. & Ambudkar, S.V. Improving cancer chemotherapy with modulators of ABC drug transporters. Curr. Drug Targets 12, 621-630 (2011).
Shugarts, S. & Benet, L.Z. The role of transporters in the pharmacokinetics of orally administered drugs. Pharm. Res. 26, 2039-2054 (2009).
Mao, Q., Lai, Y. & Wang, J. Drug transporters in xenobiotic disposition and pharmacokinetic prediction. Drug Metab. Dispos. 46, 561-566 (2018).
Kurelec, B. The multixenobiotic resistance mechanism in aquatic organisms. Crit. Rev. Toxicol. 22, 23-43 (1992).
Nicklisch, S.C.T. & Hamdoun, A. Disruption of small molecule transporter systems by transporter-interfering chemicals (TICs). FEBS Lett. 594, 4158-4185 (2020).
Romersi, R.F. & Nicklisch, S.C.T. Interactions of environmental chemicals and natural products with ABC and SLC transporters in the digestive system of aquatic organisms. Front. Physiol. 12, 767766 (2022).
Nicklisch, S.C., Rees, S.D., McGrath, A.P. et al. Global marine pollutants inhibit P-glycoprotein: environmental levels, inhibitory effects, and cocrystal structure. Sci. Adv. 2, e1600001 (2016).
Nicklisch, S.C.T., Pouv, A.K., Rees, S.D., McGrath, A.P., Chang, G. & Hamdoun, A. Transporter-interfering chemicals inhibit P-glycoprotein of yellowfin tuna (Thunnus albacares). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 248, 109101 (2021).
Hites, R.A., Foran, J.A., Carpenter, D.O., Hamilton, M.C., Knuth, B.A. & Schwager, S.J. Global assessment of organic contaminants in farmed salmon. Science 303, 226-229 (2004).
Morrissey, K.M., Wen, C.C., Johns, S.J., Zhang, L., Huang, S.M. & Giacomini, K.M. The UCSF-FDA TransPortal: a public drug transporter database. Clin. Pharmacol. Ther. 92, 545-546 (2012).
Mullard, A. 2020 FDA drug approvals. Nat. Rev. Drug Discov. 20, 85-90 (2021).
Zamek-Gliszczynski, M.J. et al. Transporters in drug development: international transporter consortium update on emerging transporters of clinical importance. Clin. Pharmacol. Ther. 112, 485-500 (2022).
Flieger, J. & Flieger, M. Ionic liquids toxicity-benefits and threats. Int. J. Mol. Sci. 21, 6267-6308 (2020).
Wei, P. et al. Emerging impacts of ionic liquids on eco-environmental safety and human health. Chem. Soc. Rev. 50, 13609-13627 (2021).
van den Poel, B., Saegeman, V. & Schuermans, A. Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control. Eur. J. Clin. Microbiol. Infect. Dis. 41, 349-362 (2022).
Malkoske, T., Tang, Y., Xu, W., Yu, S. & Wang, H. A review of the environmental distribution, fate, and control of tetrabromobisphenol a released from sources. Sci. Total Environ. 569-570, 1608-1617 (2016).
Covaci, A., Voorspoels, S., Abdallah, M.A., Geens, T., Harrad, S. & Law, R.J. Analytical and environmental aspects of the flame retardant tetrabromobisphenol-a and its derivatives. J. Chromatogr. A 1216, 346-363 (2009).
Abou-Elwafa Abdallah, M. Environmental occurrence, analysis and human exposure to the flame retardant tetrabromobisphenol-a (TBBP-A)-a review. Environ. Int. 94, 235-250 (2016).
Zuiderveen, E.A.R., Slootweg, J.C. & de Boer, J. Novel brominated flame retardants-a review of their occurrence in indoor air, dust, consumer goods and food. Chemosphere 255, 126816 (2020).
Kenner, T. The measurement of blood density and its meaning. Basic Res. Cardiol. 84, 111-124 (1989).
Nicklisch, S.C.T., Bonito, L.T., Sandin, S. & Hamdoun, A. Mercury levels of yellowfin tuna (Thunnus albacares) are associated with capture location. Environ. Pollut. 229, 87-93 (2017).
Panseri, S. et al. Persistent organic pollutants in fish: biomonitoring and cocktail effect with implications for food safety. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 36, 601-611 (2019).
Niederberger, E. & Parnham, M.J. The impact of diet and exercise on drug responses. Int. J. Mol. Sci. 22, 7692-7714 (2021).
Ash, M. & Boyce, J.K. Racial disparities in pollution exposure and employment at US industrial facilities. Proc. Natl Acad. Sci. USA 115, 10636-10641 (2018).
Yee, S.W. et al. Influence of transporter polymorphisms on drug disposition and response: a perspective from the international transporter consortium. Clin. Pharmacol. Ther. 104, 803-817 (2018).
Giacomini, K.M. et al. International transporter consortium commentary on clinically important transporter polymorphisms. Clin. Pharmacol. Ther. 94, 23-26 (2013).
Ho, R.H. et al. Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants. Pharmacogenet. Genomics 17, 647-656 (2007).
Brouwer, K.L. et al. Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group. Clin. Pharmacol. Ther. 98, 266-287 (2015).
Mooij, M.G. et al. Development of human membrane transporters: drug disposition and pharmacogenetics. Clin. Pharmacokinet. 55, 507-524 (2016).
Nigam, S.K. & Bhatnagar, V. How much do we know about drug handling by SLC and ABC drug transporters in children? Clin. Pharmacol. Ther. 94, 27-29 (2013).
Dewan, P., Jain, V., Gupta, P. & Banerjee, B.D. Organochlorine pesticide residues in maternal blood, cord blood, placenta, and breastmilk and their relation to birth size. Chemosphere 90, 1704-1710 (2013).
Mannetje, A., Coakley, J., Mueller, J.F., Harden, F., Toms, L.M. & Douwes, J. Partitioning of persistent organic pollutants (POPs) between human serum and breast milk: a literature review. Chemosphere 89, 911-918 (2012).
Schoretsanitis, G., Augustin, M., Sassmannshausen, H., Franz, C., Grunder, G. & Paulzen, M. Antidepressants in breast milk; comparative analysis of excretion ratios. Arch. Womens Ment. Health 22, 383-390 (2019).
Tobon, A.L., Habecker, E. & Forray, A. Opioid Use in Pregnancy. Curr. Psychiatry Rep. 21, 118 (2019).
Gallo, P., De Vincentis, A., Pedone, C. et al. Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. Eur. J. Intern. Med. 65, 51-57 (2019).
Akpalu, W. & Okyere, M.A. Fish protein transition in a coastal developing country. Environ. Resource Econ. 84, 825-843 (2022).
Rosenfeld, P.E., Spaeth, K.R., Remy, L.L. et al. Perfluoroalkyl substances exposure in firefighters: sources and implications. Environ. Res. 220, 115164 (2023).
Harley, K.G. et al. Determinants of pesticide concentrations in silicone wristbands worn by Latina adolescent girls in a California farmworker community: the COSECHA youth participatory action study. Sci. Total Environ. 652, 1022-1029 (2019).
Quandt, S.A., Hernandez-Valero, M.A., Grzywacz, J.G., Hovey, J.D., Gonzales, M. & Arcury, T.A. Workplace, household, and personal predictors of pesticide exposure for farmworkers. Environ. Health Perspect. 114, 943-952 (2006).
Gluge, J., Scheringer, M., Cousins, I.T. et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ. Sci. Process Impacts 22, 2345-2373 (2020).
How, Z.T. & Gamal El-Din, M. A critical review on the detection, occurrence, fate, toxicity, and removal of cannabinoids in the water system and the environment. Environ. Pollut. 268, 115642 (2021).
Colles, A. et al. Fourth WHO-coordinated survey of human milk for persistent organic pollutants (POPs): Belgian results. Chemosphere 73, 907-914 (2008).
Barupal, D.K. & Fiehn, O. Generating the blood exposome database using a comprehensive text mining and database fusion approach. Environ. Health Perspect. 127, 97008 (2019).
Wang, Z., Walker, G.W., Muir, D.C.G. & Nagatani-Yoshida, K. Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories. Environ. Sci. Technol. 54, 2575-2584 (2020).
Bijlsma, N. & Cohen, M.M. Environmental chemical assessment in clinical practice: unveiling the elephant in the room. Int. J. Environ. Res. Public Health 13, 181 (2016).
Kalia, V., Jones, D.P. & Miller, G.W. Networks at the nexus of systems biology and the exposome. Curr. Opin. Toxicol. 16, 25-31 (2019).
Raies, A.B. & Bajic, V.B. In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev. Comput. Mol. Sci. 6, 147-172 (2016).
Nigam, S.K. What do drug transporters really do? Nat. Rev. Drug Discov. 14, 29-44 (2015).
Kell, D.B. Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness. Nat. Rev. Drug Discov. 15, 143 (2016).
Nozaki, Y. & Izumi, S. Preincubation time-dependent, long-lasting inhibition of drug transporters and impact on the prediction of drug-drug interactions. Drug Metab. Dispos. 51(9), 1077-1088 (2023). https://doi.org/10.1124/dmd.122.000970.
Taskar, K.S. et al. Physiologically-based pharmacokinetic models for evaluating membrane transporter mediated drug-drug interactions: current capabilities, case studies, future opportunities, and recommendations. Clin. Pharmacol. Ther. 107, 1082-1115 (2020).
Trexler, A.W., Knudsen, G.A., Nicklisch, S.C.T., Birnbaum, L.S. & Cannon, R.E. 2,4,6-tribromophenol exposure decreases P-glycoprotein transport at the blood-brain barrier. Toxicol. Sci. 171, 463-472 (2019).
Henneberger, L., Goss, K.U. & Endo, S. Equilibrium sorption of structurally diverse organic ions to bovine serum albumin. Environ. Sci. Technol. 50, 5119-5126 (2016).
Kowalska, D., Stolte, S., Wyrzykowski, D., Stepnowski, P. & Dołżonek, J. Interaction of ionic liquids with human serum albumin in the view of bioconcentration: a preliminary study. Chem. Pap. 76, 2405-2417 (2022).
Cheng, Y., Martinez-Guerrero, L.J., Wright, S.H., Kuester, R.K., Hooth, M.J. & Sipes, I.G. Characterization of the inhibitory effects of N-butylpyridinium chloride and structurally related ionic liquids on organic cation transporters 1/2 and human toxic extrusion transporters 1/2-k in vitro and in vivo. Drug Metab. Dispos. 39, 1755-1761 (2011).
Wittwer, M.B., Zur, A.A., Khuri, N. et al. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J. Med. Chem. 56, 781-795 (2013).
Chen, E.C. et al. High throughput screening of a prescription drug library for inhibitors of organic cation transporter 3, OCT3. Pharm. Res. 39, 1599-1613 (2022).
Bruyere, A., Hubert, C., Le Vee, M. et al. Inhibition of SLC drug transporter activities by environmental bisphenols. Toxicol. In Vitro 40, 34-44 (2017).
Georgantzopoulou, A., Skoczynska, E., van den Berg, J.H. et al. P-gp efflux pump inhibition potential of common environmental contaminants determined in vitro. Environ. Toxicol. Chem. 33, 804-813 (2014).
Chedik, L., Bruyere, A., Le Vee, M. et al. Inhibition of human drug transporter activities by the pyrethroid pesticides allethrin and tetramethrin. PloS One 12, e0169480 (2017).
Pivcevic, B. & Zaja, R. Pesticides and their binary combinations as P-glycoprotein inhibitors in NIH 3T3/MDR1 cells. Environ. Toxicol. Pharmacol. 22, 268-276 (2006).
Chedik, L., Bruyere, A. & Fardel, O. Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters. Xenobiotica 49, 363-374 (2019).
Bircsak, K.M., Richardson, J.R. & Aleksunes, L.M. Inhibition of human MDR1 and BCRP transporter ATPase activity by organochlorine and pyrethroid insecticides. J. Biochem. Mol. Toxicol. 27, 157-164 (2013).